According to the above considerations, the goal of this review is to present the current information regarding the role of HuR protein in hepatocellular carcinoma (HCC), as described by in vitro experiments, in vivo animal models and clinical trials. This evidence concerns the gene ELAVL1 and hepatocellular carcinoma.